SCHEMBL18708792

SCHEMBL18708792

CCc1cc2cccc(C)c2c(=O)n1-c1cccc(F)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 4/20 0.41
NOTUM Q6P988 1/20 0.39
FAAH O00519 1/20 0.38
MGLL Q99685 1/20 0.38
METAP2 P50579 1/20 0.37
MPI P34949 1/20 0.37
MAT2A P31153 1/20 0.36
CYP1A2 P05177 2/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
POLB P06746 1/20 0.36
GRM2 Q14416 1/20 0.36
PIK3CG P48736 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
MDM2 Q00987 1/20 0.35
CASR P41180 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18708799 0.88 HKDC1 (0.44) PIK3CDCYP1A2RXFP1POLBPIK3CG
SCHEMBL12943411 0.86 PIK3CD (0.42) PIK3CDCYP1A2RXFP1POLBPIK3CG
SCHEMBL12943784 0.86 PIK3CD (0.43) PIK3CDNOTUMFAAHMGLLMETAP2
SCHEMBL16596148 0.85 NOTUM (0.48) PIK3CDNOTUMFAAHMGLLMETAP2
SCHEMBL16591320 0.81 PIK3CD (0.40) PIK3CDNOTUMFAAHMGLLMETAP2
SCHEMBL22237904 0.80 PIK3CD (0.50) PIK3CDPIK3CGCASR
SCHEMBL14757708 0.79 TGM2 (0.37) PIK3CDCYP1A2MAPTPOLBPIK3CG
SCHEMBL16689262 0.79 PIK3CD (0.45) PIK3CDNOTUMFAAHMGLLMETAP2
SCHEMBL14649148 0.79 PIK3CD (0.45) PIK3CDNOTUMFAAHMGLLMETAP2
SCHEMBL13781779 0.78 PIK3CD (0.49) PIK3CDCYP1A2PIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3811974-A1 TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS Infinity Pharmaceuticals, Inc. (US) 2021-04-28 EP disclosed
EP-3441392-A1 A PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION Intellikine, LLC (US) 2019-02-13 EP disclosed
EP-3150609-A1 PROCESS FOR PREPARING CERTAIN CHEMICAL ENTITIES Intellikine, LLC (US) 2017-04-05 EP disclosed